Skip to main content

Cepheid Plans to Offer 10 Million Shares in Follow-on Offering

NEW YORK, Feb. 24 (GenomeWeb News) - Cepheid plans to offer to the public 10 million shares of common stock, plus an option to purchase up to an additional 1.5 million sharees to cover over-allotments.

 

The company filed a preliminary prospectus supplement with the Securities and Exchange Commission today.

 

UBS Investment Bank is the sole book-running manager for the proposed offering, and the co-managers of the offering are William Blair & Company and Robert W. Baird & Co.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.